(NASDAQ: NTRB) Nutriband's forecast annual revenue growth rate of 338.01% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.17%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Nutriband's revenue in 2025 is $2,139,537.On average, 1 Wall Street analysts forecast NTRB's revenue for 2026 to be $157,106,499, with the lowest NTRB revenue forecast at $157,106,499, and the highest NTRB revenue forecast at $157,106,499. On average, 1 Wall Street analysts forecast NTRB's revenue for 2027 to be $1,064,219,455, with the lowest NTRB revenue forecast at $1,064,219,455, and the highest NTRB revenue forecast at $1,064,219,455.
In 2028, NTRB is forecast to generate $2,012,323,990 in revenue, with the lowest revenue forecast at $2,012,323,990 and the highest revenue forecast at $2,012,323,990.